Gadofosveset: the first intravascular contrast agent EU-approved for use with magnetic resonance angiography.
about
Mapping of autogenous saphenous veins as an imaging adjunct to peripheral MR angiography in patients with peripheral arterial occlusive disease and peripheral bypass grafting: prospective comparison with ultrasound and intraoperative findings.Innovation in cancer imaging.A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis.Gadofosveset--a blood pool contrast agent used with MRI to detect obscure gastrointestinal bleeding: a case report.
P2860
Gadofosveset: the first intravascular contrast agent EU-approved for use with magnetic resonance angiography.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Gadofosveset: the first intrav ...... agnetic resonance angiography.
@en
type
label
Gadofosveset: the first intrav ...... agnetic resonance angiography.
@en
prefLabel
Gadofosveset: the first intrav ...... agnetic resonance angiography.
@en
P2860
P356
P1433
P1476
Gadofosveset: the first intrav ...... agnetic resonance angiography.
@en
P2093
Mathias Goyen
P2860
P356
10.2217/14796678.3.1.19
P577
2007-01-01T00:00:00Z